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Rodriguez-Lopez and colleagues [1] describe a replication
study of our previous association between osteoarthritis (OA)
and asporin [2]. The authors were unable to find this
association in the Spanish population and question the
association we found in the Japanese population. Their report
also contains an interpretation of two previous papers on the
same topic [3,4] that differs from those of the original study
authors. We have concerns about their interpretation of data
and about the conclusions drawn.
It is not surprising that an association of a gene with a
disease is found in some populations but not in others. Such
diversity has been established for many common complex
diseases with several explanations [5]. In this particular case,
one explanation is the difference in the inclusion criteria used
to recruit study participants. Whereas we recruited sympto-
matic OA patients with supporting radiographic evidence,
Rodriguez-Lopez and colleagues used joint replacement
surgery as inclusion criteria (Table 1).
Another explanation is ethnic diversity, which is apparent in
the very different allelic frequencies between the Spanish and
Japanese populations. We question the authors’ generaliza-
tion of the three European populations (Spanish, Greek and
UK) as ‘European Caucasian’, given the diverse frequencies
of asporin alleles in the three populations [1,3,4] (Table 2), as
well as their history and geography. The Spanish population
in particular is distinct from the others; for example, the
frequency of the common allele, Asp13 (D13), in the Spanish
control groups shows statistically significant differences
(p = 0.00088 versus UK; p = 0.021 versus Greek). The allelic
frequency in hip OA also is very different.
However, it is notable that in studies of knee OA for all three
European populations, the allelic frequency of D13 is
decreased and that of D14 is increased in the case group –
the same trend observed in our Japanese study (Table 2). In
all four populations, the odds ratios exceed 1. Given that the
deviation of the odds ratio is random, the probability for its
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CI = confidence interval; D13 = Asp13; D14 = Asp14; OA = osteoarthritis.
Table 1
Association studies of asporin and osteoarthritis
Case
Study Knee Hip Total Control Association Inclusion criteria
Japan 530 593 1123 608 Knee, hip OA Symptomatic OA with radiograph
UK 278 904 1182 748 Male hip OA TKR/THR
Greece 155 (–) 155 190 Decrease of D13 TKR
Spain 188 303 491 294 None TKR/THR
OA, osteoarthritis; THR, total hip replacement; TKR, total knee replacement; –, not studied.Page 2 of 3
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occurrence by chance is (1/2)4 = 1/16, which is substantially
low. If we combine data for all three European populations, the
association becomes significant (p = 0.030; odds ratio 1.26,
95% confidence interval 1.02 to 1.56). We believe that this
estimation is valid because the inclusion criteria are the same,
provided that the ethnicity is consistent as the Spanish group
itself proposed. If so, the association of asporin has been
replicated in the European Caucasian population. The low
odds ratio given above suggests that the Spanish study might
be under-powered to detect the low-risk gene. It remains
under-powered even when we postulate the moderate risk
(power = 0.56 to 0.71 at a relative risk of 1.4 to 1.5 [6]).
OA is a serious disease with global impact, and it has proven
refractory to genetic (etiologic) study. The questions raised
by Rodriguez-Lopez and colleagues [1] provide further
incentive to build common platforms for phenotype definition,
inclusion criteria, genotyping and analytical methods, and to
unite the ethnically diverse resources available for study.
Such efforts would increase the accuracy and power of the
research for our ‘common’ enemy.
Table 2
Allelic frequencies of D13 and D14 repeats of asporin in
osteoarthristis
Allelic frequency (%)
D13 repeat D14 repeat
Study Case Control Case Control
Knee
Japan 58.7 65.2 8.6 4.8
UK 46.4 50.3 13.7 12.7
Greece 38.1 49.7 15.2 13.9
Spain 41.5 42.2 14.9 12.6
Hip
Japan 61.6 64.0 7.9 4.8
UK 47.5 50.3 14.3 12.7
Spain 43.3 42.2 9.7 12.6
Authors’ response
Julio Rodriguez-Lopez, Manuel Pombo-Suarez, Myriam Liz, Juan J Gomez-Reino and Antonio Gonzalez
The letter from Ikegawa and colleagues highlights some
difficulties in defining what constitutes replication of previous
genetic association in the context of studies with different
patient selections, ethnicities, environmental and cultural
influences and a multiplicity of tests. Our article [1] did not
question the results described in the Japanese population [2].
We merely concluded that, among European Caucasians,
there was no evidence for an important effect of the asporin
D repeat polymorphism; this was similar to the conclusion of
the authors of the UK study [3].
Our conclusion was based in the analysis of the three
available studies in Europeans [1,3,4]. We were well aware of
differences in allele frequencies between the European
populations and, consequently, we used the appropriate
techniques to combine data. All the comparisons done were
not significant or were, at best, inconclusive. For example, in
the comparison between D14 and D13 allele frequencies in
relation to knee OA that is mentioned by Ikegawa and
colleagues, the crude combination of data shows a significant
effect, but it is not significant if the variability between studies
is adequately accounted for (Mantel–Haenszel odds ratio
1.23; 95% confidence interval 0.99 to 1.56; p = 0.07).
Ikegawa and colleagues also call our attention to the
coincidence in direction of the odds ratio from the different
studies in relation to knee OA, giving its probability as 1/16 =
0.0625, and that this is unlikely to have occurred by chance
alone. However, this analysis includes the result used as
reference, the Japanese study, in the subject of the
comparison. The correct probability is 1/8 = 0.125.
Regarding the comment on the power of our study, we have
already shown that it is enough to detect effects of the size
observed in the Japanese study (with the exceptions
mentioned in our article). In addition, the larger power of the
combined European studies did not result in significant
differences, as made explicit in this reply.
In essence, our conclusion is fully supported by the available
evidence. In our article we were careful not to rule out a role
of the asporin D repeat polymorphism in OA susceptibility
among Caucasians. Only an important effect, similar to that
found in the Japanese study, was excluded.
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